The role of anger/hostility in treatment-resistant depression: A secondary analysis from the ADAPT-A study
LB Fisher, M Fava, GD Doros, JE Alpert… - The Journal of …, 2015 - journals.lww.com
Major depressive disorder is often accompanied by elevated levels of anger, hostility, and
irritability, which may contribute to worse outcomes. The present study is a secondary …
irritability, which may contribute to worse outcomes. The present study is a secondary …
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)
M Fava, MP Freeman, M Flynn, BB Hoeppner… - Brain stimulation, 2018 - Elsevier
Abstract Background Low-Field Magnetic Stimulation (LFMS) is a novel, non-invasive, sub-
threshold neuromodulation technique, shown in preliminary studies to have immediate …
threshold neuromodulation technique, shown in preliminary studies to have immediate …
Existential dynamic therapy (“VITA”) for treatment-resistant depression with Cluster C disorder: matched comparison to treatment as usual
G Stålsett, T Gude, MH Rønnestad… - Psychotherapy …, 2012 - Taylor & Francis
Existential suffering may contribute to treatment-resistant depression. The “VITA” treatment
model was designed for such patients with long-standing depression accompanied by …
model was designed for such patients with long-standing depression accompanied by …
Switching from inadequate adjunctive or combination treatment options to brexpiprazole adjunctive to antidepressant: an open-label study on the effects on …
M Fava, T Okame, Y Matsushima, P Perry… - International Journal …, 2017 - academic.oup.com
Background: Approximately 50% of patients with major depressive disorder do not respond
adequately to their antidepressant treatment, underscoring the need for more effective …
adequately to their antidepressant treatment, underscoring the need for more effective …
Evidence for two types of bipolar depression using a dimensional approach
C Henry, K M'Baïlara, R Poinsot, AA Casteret… - Psychotherapy and …, 2007 - karger.com
Background: Although there is a great heterogeneity of depressive states in bipolar patients,
there is only one definition in international classifications for describing them. However, this …
there is only one definition in international classifications for describing them. However, this …
Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis
Objective: Preliminary evidence suggested that sertraline might be slightly superior to other
antidepressant medications in terms of efficacy. The aim of this study was to carry out a …
antidepressant medications in terms of efficacy. The aim of this study was to carry out a …
[图书][B] The use and misuse of psychiatric drugs: an evidence-based critique
J Paris - 2011 - books.google.com
" Dr. Paris has written an honest, balanced presentation of the ways in which psychiatric
drugs are evaluated and prescribed. He highlights the complexity of the task, the limits of …
drugs are evaluated and prescribed. He highlights the complexity of the task, the limits of …
Quetiapine: novel uses in the treatment of depressive and anxiety disorders
AV Ravindran, A Al-Subaie… - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: Quetiapine, an atypical antipsychotic, has been approved for the
treatment of schizophrenia, acute mania, bipolar depression and unipolar major depression …
treatment of schizophrenia, acute mania, bipolar depression and unipolar major depression …
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
S Luan, H Wan, L Zhang, H Zhao - Neuropsychiatric disease and …, 2018 - Taylor & Francis
Background Treatment-resistant depression (TRD) is common and potentially life-
threatening in adults, and the benefits and risks of adjunctive aripiprazole in these patients …
threatening in adults, and the benefits and risks of adjunctive aripiprazole in these patients …
Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
E Weiller, C Weiss, CP Watling, C Edge… - Neuropsychiatric …, 2017 - Taylor & Francis
Objective Patients with major depressive disorder (MDD) with inadequate response to
antidepressant treatment (ADT) may suffer a prolonged loss of functioning. This review …
antidepressant treatment (ADT) may suffer a prolonged loss of functioning. This review …